Used PandaOmics and Chemistry42 AI systems to design PROTAC molecules targeting Bruton's tyrosine kinase for leukemias and lymphomas
Reported: AI-driven pipeline collapsed drug selection to 12-18 months versus 2.5-4 years with traditional methods; results published in the Journal of Medicinal Chemistry
Using Anthropic's Claude models, starting with Claude Science on specific R&D workflows, to accelerate drug discovery and AI-driven software development across the company
Amgen, Moderna, the Allen Institute, and Thermo Fisher received OpenAI's GPT-Rosalind vertical reasoning model as a research preview for drug discovery and genomics work.
Novo Nordisk partnered with OpenAI to overhaul drug development, with pilots starting immediately in R&D, manufacturing, and commercial and full integration planned by year-end.
Every entry names the organisation and links its source. Outcome figures are quoted as reported, never estimated. Vendor announcements without a named customer are excluded. Halted and reversed deployments are kept on purpose.
Usamos cookies esenciales para que el sitio funcione (inicio de sesión, seguridad de los formularios). Con tu permiso, también usamos cookies de analítica para entender cómo usas el sitio.
Política de privacidad